نوع مقاله : اصیل پژوهشی
نویسندگان
1 دستیار گروه زنان و زایمان، فلوشیپ انکولوژی زنان، دانشکده پزشکی، دانشگاه علوم پزشکی اردبیل، اردبیل، ایران.
2 دانشیار گروه زنان و زایمان، دانشکده پزشکی، دانشگاه علوم پزشکی اردبیل، اردبیل، ایران.
3 استادیار گروه زنان و زایمان، دانشکده پزشکی، دانشگاه علوم پزشکی اردبیل، اردبیل، ایران.
4 دانشیار گروه پزشکی اجتماعی، دانشکده پزشکی، دانشگاه علوم پزشکی اردبیل، اردبیل، ایران.
چکیده
کلیدواژهها
موضوعات
عنوان مقاله [English]
نویسندگان [English]
Introduction: Cesarean scar ectopic pregnancy (CSP) is a potentially life-threatening condition associated with high risk of uterine rupture and severe maternal complications. This study was conducted with aim to evaluate the outcomes of different treatment modalities for CSP.
Methods: This retrospective cross-sectional study was conducted on 120 patients diagnosed with CSP at Alavi Medical Training Center in Ardabil between 2016 and 2021. Patients were treated with one of five approaches: (1) laparotomy, (2) hysteroscopy and curettage, (3) hysteroscopy and curettage following systemic methotrexate, (4) systemic methotrexate alone, or (5) systemic methotrexate combined with potassium hydroxide. Data were analyzed using SPSS software (version 26) and Shapiro-Wilk, ANOVA, independent t-test, Kruskal-Wallis, Mann-Whitney, Chi-square, and Fisher’s exact tests. P<0.05 was considered statistically significant.
Results: History of placenta accreta was observed in 4 patients (3.3%), prior dilatation and curettage in 14 (11.7%), manual removal of placenta in 5 (4.2%), and IVF in 2 (1.7%). Fetal heartbeat was absent in 78 patients (65%). Pre-treatment β-HCG levels were <5000 mIU/mL in 37 patients (30.8%) and >5000 mIU/mL in 83 (69.2%). Significant differences were observed among treatment groups in terms of complete mass resolution, duration of hospitalization, blood transfusion requirement, intraoperative blood loss, and β-HCG normalization speed (p<0.001). However, secondary infection (p=0.15) and hysterectomy rates (p=0.17) were not significantly different.
Conclusion: Combined treatment with systemic methotrexate and hysteroscopy with curettage demonstrated the highest success rate and lowest complications in cesarean scar ectopic pregnancies.
کلیدواژهها [English]